Evaluation of the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen

A12-week single-center, open-label, clinical study is being conducted to assess the efficacy and tolerability of the Brightening Treatment paired with a skincare regimen on healthy female subjects aged 20-65 years with Fitzpatrick Skin Types I - VI and moderate global facial pigmentation due to sun exposure, blemishes, and/or procedures when applied by a clinician in a series of 4 sessions at 2-week intervals. The procedure in this clinical study will include the brightening treatment, retinol serum, and a post-procedure cream. The study visits include baseline, week 2, 6, and 12.

NCT Number	NCT07501000
Lead Sponsor	Revision Skincare
Conditions	Hyperpigmentation, Skin Ageing, Post Inflammatory Hyperpigmentation, Skin Roughness
Enrollment	11 participants
Start Date	2024-10-07
Primary Completion	2025-01-23 (estimated)
Study Completion	2025-01-23 (estimated)
Updated on ClinicalTrials.gov	2026-06-05